
Photo taken from Lisa Newcomb/LinkedIn
Jun 30, 2024, 13:53
Long-Term Outcomes From Prostate Cancer Active Surveillance
Avirup Guha, Director of Cardio-Oncology at Georgia Cancer Center, shared on X: .
“Long-Term Outcomes From Prostate Cancer Active Surveillance.
Wondering what other disease patients had? Heart disease? OS (Overall Survival) at 15 years is almost 16%. PCSM (Prostate Cancer-Specific Mortality) is super low.”
Source: Avirup Guha/X
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Feb 21, 2025, 14:13
Feb 21, 2025, 13:29
Feb 21, 2025, 13:07
Feb 21, 2025, 13:06
Feb 21, 2025, 13:03
Feb 21, 2025, 13:00
Feb 21, 2025, 12:53